Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00127387 · ClinicalTrials.gov registry record · Phase 2
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
A Phase 2 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00127387 is a Phase 2 study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 54 participants.
The verdict
NCT00127387, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
Patients who receive radiation therapy often have fatigue or a decrease in feeling well causing a "wasting" away. For patients with advanced disease of lung cancer, prostate cancer, or cancer that has spread to the bone, it is hoped that this drug may decrease this. If patients feel better during treatments they can complete the therapy without any breaks in treatment. For treatment to be most effective, it should be given in the amount needed, on a particular schedule.
Interventions
- DRUG Enbrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2001-05 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00127387
The ClinicalTrials.gov registry entry for NCT00127387 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enbrel is the first listed.
NCT00127387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00127387 about?
NCT00127387 is a clinical study titled "Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia". Patients who receive radiation therapy often have fatigue or a decrease in feeling well causing a "wasting" away. For patients with advanced disease of lung cancer, prostate cancer, or cancer that has spread to the bone, it is hoped that this drug may decrease this. If patients feel better during tr...
What is the current status of trial NCT00127387?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2001-05. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00127387?
The interventions under investigation include: Enbrel (DRUG).
Who is sponsoring clinical trial NCT00127387?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.